Skip to main content
UniHealth

Doctor search

Kimberly Heller Allison, MD

Pathology · Stanford

NPI 1184661811

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Allison’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence C55708 · Current

Licensed to practise in California · since 2013 · expires 2028-10-31 · New York Medical College.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

  • Washington MD.MD.00043642Physician And Surgeon License · since 2004 · expires 2013-10-28
    ExpiredNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$69,310

Medicare paid this office $69,310 for 338 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Pathology examination of tissue using a microscope, moderately high complexity82$24,200$74
Microscopic genetic analysis of tumor, manual101$12,268$36
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure83$8,272$57
Surgical pathology consultation and report on referred slides prepared elsewhere101$7,479$71
Pathology examination of tissue using a microscope, intermediate complexity121$5,228$32
See all 10 services
Every Original Medicare service billed
Pathology examination of tissue using a microscope, moderately high complexity82$24,200$74
Microscopic genetic analysis of tumor, manual101$12,268$36
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure83$8,272$57
Surgical pathology consultation and report on referred slides prepared elsewhere101$7,479$71
Pathology examination of tissue using a microscope, intermediate complexity121$5,228$32
Special stained specimen slides to examine tissue, each additional procedure67$3,956$25
Special stained specimen slides to examine tissue, initial procedure95$3,845$31
Pathology examination of specimen during surgery, first tissue block20$2,419$56
Surgical pathology consultation and report on referred material requiring preparation of slides12$953$79
Pathology examination of tissue using a microscope, moderately low complexity13$222$10

Who their Medicare patients are

338 Original Medicare patients in 2024. Average age 73 · Under 65 5% · 85 and older 7% · Women 96% · Also on Medicaid 17% · Health risk score 1.13. At or below the middle of the specialty; the typical pathology clinician is at 1.55.

Conditions among them: Cancer 75% · High blood pressure 62% · Diabetes 27% · Coronary heart disease 18% · Depression 18% · Chronic kidney disease 17% · Atrial fibrillation 13% · Heart failure 11% · COPD 9% · Stroke 6%.

The office billed $935,662, Medicare allowed $88,184 and paid $69,310; for 1,457 services of 17 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20243381,457731.13$935,662$69,310
20233941,462721.19$813,025$71,345
20223791,732731.04$666,525$81,159
20213281,530731.03$471,775$75,843
20202961,361731.02$385,035$68,653
2019235967721.19$257,256$48,222
20183271,387711.13$353,123$67,981
20173291,424711.13$368,575$78,916
20163101,379710.98$356,446$71,774
20152811,126721.06$288,979$59,167
20143021,248701.01$313,817$64,345
2013209868701.08$206,627$43,382

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 9 services

Original Medicare services billed in 2023
Pathology examination of tissue using a microscope, moderately high complexity84$22,344$77
Microscopic genetic analysis of tumor, manual107$15,790$38
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure142$9,326$59
Pathology examination of tissue using a microscope, intermediate complexity139$6,679$34
Surgical pathology consultation and report on referred slides prepared elsewhere83$6,545$76
Special stained specimen slides to examine tissue, each additional procedure63$3,505$26
Special stained specimen slides to examine tissue, initial procedure86$3,276$32
Pathology examination of specimen during surgery, first tissue block23$2,567$58
Surgical pathology consultation and report on referred material requiring preparation of slides11$887$81

2022: 10 services

Original Medicare services billed in 2022
Pathology examination of tissue using a microscope, moderately high complexity97$23,708$77
Microscopic genetic analysis of tumor, manual137$19,786$39
Pathology examination of tissue using a microscope, intermediate complexity169$8,265$35
Surgical pathology consultation and report on referred slides prepared elsewhere101$8,092$78
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure91$5,978$59
Special stained specimen slides to examine tissue, each additional procedure71$5,562$26
Special stained specimen slides to examine tissue, initial procedure107$4,651$33
Pathology examination of specimen during surgery, first tissue block27$2,525$59
Surgical pathology consultation and report on referred material requiring preparation of slides12$976$81
Pathology examination of tissue using a microscope, moderately low complexity16$256$11

2021: 11 services

Original Medicare services billed in 2021
Pathology examination of tissue using a microscope, moderately high complexity84$22,595$79
Microscopic genetic analysis of tumor, manual129$18,865$40
Pathology examination of tissue using a microscope, intermediate complexity141$7,302$36
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure110$7,114$60
Surgical pathology consultation and report on referred slides prepared elsewhere80$6,216$78
Special stained specimen slides to examine tissue, each additional procedure46$3,860$27
Special stained specimen slides to examine tissue, initial procedure72$3,279$33
Surgical pathology consultation and report on referred material requiring preparation of slides27$2,229$83
Pathology examination of specimen during surgery, first tissue block19$1,790$60
Pathology cytologic examination of specimen during surgery, initial site13$1,668$60
Pathology examination of tissue using a microscope, moderately low complexity17$260$11

2020: 10 services

Original Medicare services billed in 2020
Pathology examination of tissue using a microscope, moderately high complexity89$22,620$82
Microscopic genetic analysis of tumor, manual115$17,389$41
Pathology examination of tissue using a microscope, intermediate complexity127$5,841$36
Surgical pathology consultation and report on referred slides prepared elsewhere62$5,078$77
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure61$3,998$62
Special stained specimen slides to examine tissue, each additional procedure46$3,982$28
Special stained specimen slides to examine tissue, initial procedure71$3,044$35
Pathology examination of specimen during surgery, first tissue block25$2,905$62
Surgical pathology consultation and report on referred material requiring preparation of slides12$1,096$84
Pathology examination of tissue using a microscope, moderately low complexity20$321$10

2019: 8 services

Original Medicare services billed in 2019
Pathology examination of tissue using a microscope, moderately high complexity56$13,364$79
Microscopic genetic analysis of tumor, manual80$11,581$40
Surgical pathology consultation and report on referred slides prepared elsewhere68$5,459$78
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure61$4,164$60
Pathology examination of tissue using a microscope, intermediate complexity79$3,996$36
Special stained specimen slides to examine tissue, each additional procedure42$3,283$28
Surgical pathology consultation and report on referred material requiring preparation of slides28$2,329$83
Special stained specimen slides to examine tissue, initial procedure57$2,231$34

2018: 11 services

Original Medicare services billed in 2018
Pathology examination of tissue using a microscope, moderately high complexity91$20,097$79
Microscopic genetic analysis of tumor, manual115$17,097$43
Pathology examination of tissue using a microscope, intermediate complexity147$7,086$34
Surgical pathology consultation and report on referred slides prepared elsewhere81$6,460$78
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure70$4,547$60
Special stained specimen slides to examine tissue, each additional procedure62$4,482$27
Special stained specimen slides to examine tissue, initial procedure85$3,453$34
Pathology examination of specimen during surgery, first tissue block18$1,519$61
Surgical pathology consultation and report on referred material requiring preparation of slides17$1,398$82
Pathology cytologic examination of specimen during surgery, initial site11$911$61
Pathology examination of tissue using a microscope, moderately low complexity17$265$11

2017: 12 services

Original Medicare services billed in 2017
Pathology examination of tissue using a microscope, moderately high complexity94$26,710$80
Microscopic genetic analysis of tumor, manual111$20,885$52
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure99$6,570$60
Pathology examination of tissue using a microscope, intermediate complexity132$6,327$35
Surgical pathology consultation and report on referred slides prepared elsewhere77$6,179$79
Special stained specimen slides to examine tissue, initial procedure67$2,770$34
Special stained specimen slides to examine tissue, each additional procedure39$2,521$27
Surgical pathology consultation and report on referred material requiring preparation of slides23$1,959$82
Pathology examination of specimen during surgery, first tissue block19$1,446$60
Pathology cytologic examination of specimen during surgery, initial site14$1,090$61
Pathology examination of tissue using a microscope, moderately low complexity18$364$11
Pathology examination of tissue using a microscope, limited examination13$69$4

2016: 12 services

Original Medicare services billed in 2016
Pathology examination of tissue using a microscope, moderately high complexity98$23,718$78
Microscopic genetic analysis of tumor, manual104$19,893$50
Surgical pathology consultation and report on referred slides prepared elsewhere86$6,604$76
Pathology examination of tissue using a microscope, intermediate complexity130$6,224$34
Special stained specimen slides to examine tissue, each additional procedure50$2,562$25
Special stained specimen slides to examine tissue, initial procedure67$2,511$33
Microscopic genetic analysis of tissue, manual, initial procedure58$2,201$36
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure32$2,045$58
Pathology examination of specimen during surgery, first tissue block20$1,523$59
Pathology cytologic examination of specimen during surgery, initial site20$1,413$59
Surgical pathology consultation and report on referred material requiring preparation of slides13$1,030$79
Pathology examination of tissue using a microscope, moderately low complexity25$375$10

2015: 11 services

Original Medicare services billed in 2015
Pathology examination of tissue using a microscope, moderately high complexity83$20,396$79
Microscopic genetic analysis of tumor, manual83$15,729$50
Surgical pathology consultation and report on referred slides prepared elsewhere83$6,517$78
Pathology examination of tissue using a microscope, intermediate complexity104$5,039$35
Microscopic genetic analysis of tissue, manual, initial procedure77$3,354$39
Pathology cytologic examination of specimen during surgery, initial site20$2,016$59
Special stained specimen slides to examine tissue, initial procedure46$1,695$33
Surgical pathology consultation and report on referred material requiring preparation of slides16$1,296$76
Special stained specimen slides to examine tissue, each additional procedure25$1,126$20
Pathology examination of tissue using a microscope, moderately low complexity18$361$11
Pathology examination of tissue using a microscope, limited examination12$53$4

2014: 11 services

Original Medicare services billed in 2014
Pathology examination of tissue using a microscope, moderately high complexity104$22,992$76
Microscopic genetic analysis of tumor, manual76$13,928$48
Microscopic genetic analysis of tissue, manual, initial procedure55$7,036$57
Pathology examination of tissue using a microscope, intermediate complexity124$7,002$34
Surgical pathology consultation and report on referred slides prepared elsewhere81$6,434$71
Pathology examination of specimen during surgery, first tissue block21$2,111$57
Pathology cytologic examination of specimen during surgery, initial site15$1,377$57
Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain31$909$27
Pathology examination of tissue using a microscope, moderately low complexity28$502$10
Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)14$336$11
Pathology examination of tissue using a microscope, limited examination16$73$4

2013: 10 services

Original Medicare services billed in 2013
Pathology examination of tissue using a microscope, moderately high complexity69$11,220$73
Microscopic genetic analysis of tumor, manual56$8,734$47
Pathology examination of tissue using a microscope, intermediate complexity101$6,297$32
Surgical pathology consultation and report on referred slides prepared elsewhere53$5,950$73
Microscopic genetic analysis of tissue, manual, initial procedure30$3,249$54
Special stained specimen slides to examine tissue, initial procedure33$3,051$38
Pathology examination of tissue using a microscope, high complexity13$1,729$124
Pathology examination of specimen during surgery, first tissue block13$1,114$56
Pathology cytologic examination of specimen during surgery, initial site13$1,065$56
Pathology examination of tissue using a microscope, moderately low complexity13$211$10

Medicaid work

$1,524 in 2024

Medicaid paid $1,524 for 31 billed services this clinician did in 2024, up to 15 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Consultation and report on referred slides prepared elsewhere14$796
TISSUE EXAM BY PATHOLOGIST17$728
Medicaid work by year
202431215$1,524
202362313$3,691
202240214$3,111
202112112$642
202025113$1,108
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Morphometric analysis, tumor immunohistochemistry (eg, Her-2/neu, estrogen receptor/progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody stain procedure; manual23$2,157
TISSUE EXAM BY PATHOLOGIST27$1,156
Consultation and report on referred slides prepared elsewhere12$378

2022

Largest Medicaid services in 2022
TISSUE EXAM BY PATHOLOGIST26$1,582
Morphometric analysis, tumor immunohistochemistry (eg, Her-2/neu, estrogen receptor/progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody stain procedure; manual14$1,529

2021

Largest Medicaid services in 2021
TISSUE EXAM BY PATHOLOGIST12$642

2020

Largest Medicaid services in 2020
TISSUE EXAM BY PATHOLOGIST25$1,108

Money from drug and device companies

$51 in 2022

Industry payments by year
202211None$51
202114$3,445$3,560
202011$2,613$2,613

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AstraZeneca Pharmaceuticals LPEnhertu$51
1 payment
  • Meals for Enhertu · 2022-03-21 · $51
See the published payment
Every published payment
AstraZeneca Pharmaceuticals LPMeals · 2022-03-21Enhertu$51
See earlier years (2021, 2020)

2021: $3,560

Payments by company in 2021
Leica MicrosystemsOriginal Mammotome$3,560
4 payments
  • Consulting for Original Mammotome · 2021-11-08 · $530
  • Consulting for Original Mammotome · 2021-08-16 · $1,590
  • Consulting for Original Mammotome · 2021-05-17 · $1,325
  • Meals for Biopsy Site Identifiers · 2021-04-28 · $115

2020: $2,613

Payments by company in 2020
Eli Lilly andNone$2,613
1 payment
  • Consulting · 2020-09-01 · $2,613

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1184661811
Licence
CA C55708, WA MD00043642California C55708: Current · expires 2028-10-31Washington MD.MD.00043642: Expired
Trained
New York Medical College, 2001
Gender
Female
More record details
Sole proprietor
No
Medicaid ID
WA 8455180
Taxonomy
Federal specialty code 207ZP0102X (207ZP0102X); Federal specialty code 207ZP0101X (207ZP0101X)
Mailing address
300 Pasteur Drive, Stanford Medical Center, Dept of Pathology, Lane 235, Stanford, CA, 94305
NPI first listed
2006-06-01
NPI last updated
2024-03-13
NPI record certified
2024-03-13

This is when the NPI record was last certified, not a medical board exam.